PRE-ACT-01: an international, multicenter, randomized study on communicating a personalized AI-based lymphedema risk to breast cancer patients

M. Bergeaud, T. Rattay, K. Verhoeven, A. Lamrani-Ghaouti, C. Gaudin, G. Bologna, G. Cortellessa, A. Dekker, F. Fracasso, M. Joore, I. Koutsopoulos, Y. Liang, A. Panisson, A. Perotti, B. Ramaekers, C. Roumen, J. van Soest, H. Stobart, C. J. Talbot, A. Webb, A. Bombezin-Domino, R. Ghodssighassemabadi, S. Michiels, S. Rivera. Accepted abstract, ESTRO 2026 (Stockholm, Sweden).